General Information of This Metabolic Reaction (MR) (ID:
MR003508) |
Formula |
|
Reactant |
DOPA |
Product |
DOPP |
Reactant Info
|
Product Info
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Produce The Reactant of This MR
|
|
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
Scalable Asymmetric Syntheses of Foslevodopa and Foscarbidopa Drug Substances for the Treatment of Parkinson's Disease
|
2 |
Potent inhibitory effects of tyrosine metabolites on dihydropteridine reductase from human and sheep liver
|
3 |
Catabolism of L-phenylalanine and L-tyrosine by Rhodobacter sphaeroides OU5 occurs through 3,4-dihydroxyphenylalanine Res Microbiol. 2007 Jul-Aug;158(6):506-11. doi: 10.1016/j.resmic.2007.04.008.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.